Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis

Bisgaard, 1985, Bronchial hyperreactivity to leukotriene D4 and histamine in exogenous asthma, BMJ, 290, 1468, 10.1136/bmj.290.6480.1468 Bisgaard, 1986, Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans, Clin Allergy, 16, 289, 10.1111/j.1365-2222.1986.tb01960.x Garcia-Marcos, 1999, New perspectives for asthma treatment: antileukotriene drugs, Pediatr Allergy Immunol, 10, 77, 10.1034/j.1399-3038.1999.00006.x Busse, 1992, Eosinophils in asthma, Ann Allergy, 68, 286 Laitinen, 1993, Leukotriene E4 and granulocyte infiltration into asthmatic airways, Lancet, 341, 989, 10.1016/0140-6736(93)91073-U Terada, 1994, Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy, J Allergy Clin Immunol, 94, 629, 10.1016/0091-6749(94)90140-6 O'Shaughnessy, 1993, Differential effects of fluticasone propionate on allergen evoked bronchoconstriction and increased urinary leukotriene E4 excretion, Am Rev Respir Dis, 147, 1472, 10.1164/ajrccm/147.6_Pt_1.1472 Dworski, 1994, Effect of oral prednisone on airway inflammatory mediators in atopic asthma, Am J Respir Crit Care Med, 149, 953, 10.1164/ajrccm.149.4.8143061 Meltzer, 2000, Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo controlled clinical trial, J Allergy Clin Immunol, 105, 917, 10.1067/mai.2000.106040 Kurowski, 2004, Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation, Allergy, 59, 280, 10.1046/j.1398-9995.2003.00416.x Philip, 2002, Montelukast for treating seasonal allergic rhinitis: a randomized, double blind, placebo controlled trial performed in the spring, Clin Exp Allergy, 32, 1020, 10.1046/j.1365-2222.2002.01422.x van Adelsberg, 2003, Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 90, 214, 10.1016/S1081-1206(10)62144-8 Nayak, 2002, Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double blind, placebo controlled trial performed in the fall, Ann Allergy Asthma Immunol, 88, 592, 10.1016/S1081-1206(10)61891-1 Patel, 2005, Randomized, double-blind, placebocontrolled study of montelukast for treating perennial allergic rhinitis, Ann Allergy Asthma Immunol, 95, 551, 10.1016/S1081-1206(10)61018-6 Chen, 2006, Randomized placebocontrolled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr, Pediatr Allergy Immunol, 17, 49, 10.1111/j.1399-3038.2005.00351.x Bousquet, 2001, Allergic Rhinitis and its Impact on Asthma (ARIA), J Allergy Clin Immunol, 108, S150, 10.1067/mai.2001.118891 Khachikian, 2003, Use of montelukast in seasonal allergic rhinitis, Drug Class Rev, 2, 1 Hilberg, 2002, Objective measurement of nasal airway dimensions using acoustic rhinometry: methodological and clinical aspects, Allergy, 57, 5, 10.1046/j.0908-665x.2001.all.doc.x Greiff, 1990, The “nasal pool” device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions, Clin Exp Allergy, 20, 253, 10.1111/j.1365-2222.1990.tb02680.x Quanjer, 1993, Standardization of lung function testing: official statement of the European Respiratory Society, Eur Respir J Suppl, 16, 1 Higashi, 2003, Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis, Allergy, 58, 476, 10.1034/j.1398-9995.2003.00159.x Borish, 2003, Allergic rhinitis: systemic inflammation and implications for management, J Allergy Clin Immunol, 112, 1021, 10.1016/j.jaci.2003.09.015 Bisgaard, 1987, SRS-A leukotrienes decrease the activity of humanrespiratory cilia, Clin Allergy, 17, 95, 10.1111/j.1365-2222.1987.tb02326.x Knani, 1992, Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis, J Allergy Clin Immunol, 90, 880, 10.1016/0091-6749(92)90460-J Volovitz, 1988, Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children, J Allergy Clin Immunol, 82, 414, 10.1016/0091-6749(88)90000-0 Reicin, 2000, Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma, Arch Intern Med, 160, 2481, 10.1001/archinte.160.16.2481 Rouquet, 1997, Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics, Am J Respir Crit Care Med, 155, 1856, 10.1164/ajrccm.155.6.9196086 Altman, 1998, A placebo controlled, dose ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist, J Allergy Clin Immunol, 102, 50, 10.1016/S0091-6749(98)70054-5 Pullerits, 2002, Comparison of nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis, J Allergy Clin Immunol, 109, 949, 10.1067/mai.2002.124467